CaliberCos (NASDAQ: CWD) hit with $1 Nasdaq warning as shares stay below $1
Rhea-AI Filing Summary
CaliberCos Inc. (CWD) reports that on August 21, 2026 it received a notice from Nasdaq that the bid price of its Class A common stock has closed below $1.00 per share for 33 consecutive business days, causing non-compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement for the Nasdaq Capital Market. The notice does not immediately affect trading of the stock on Nasdaq. CaliberCos has a 180-calendar day grace period through February 17, 2027 to regain compliance by maintaining a closing bid of at least $1.00 for at least ten consecutive business days. If it fails to regain compliance, the company may qualify for an additional 180-day period if it meets other Nasdaq listing criteria and indicates an intent to cure, potentially through a reverse stock split. If ultimately unsuccessful, the common stock could be delisted from Nasdaq and is expected to trade on an OTC Markets Group marketplace. CaliberCos states it intends to closely monitor its bid price and consider all available options to address the deficiency.
Positive
- None.
Negative
- CaliberCos is out of compliance with Nasdaq Listing Rule 5550(a)(2) after its stock traded below $1.00 for 33 consecutive business days, creating a risk of Nasdaq delisting if compliance is not regained.
- The company faces a potential move from Nasdaq to an OTC Markets Group marketplace if it cannot successfully resolve the minimum bid price deficiency, which could reduce trading liquidity and visibility.
8-K Event Classification
Key Figures
Key Terms
Nasdaq Listing Rule 5550(a)(2) regulatory
Minimum Bid Requirement regulatory
grace period regulatory
reverse stock split financial
OTC Markets Group market
FAQ
Why did CaliberCos Inc. (CWD) receive a Nasdaq non-compliance notice?
How long does CWD have to regain Nasdaq minimum bid price compliance?
What happens if CaliberCos (CWD) does not regain compliance by February 17, 2027?
Could CWD be delisted from Nasdaq, and where might it trade instead?
AI-generated analysis. How Rhea-AI works. Not financial advice.